These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37828547)

  • 1. Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial.
    Yanase F; Spano S; Maeda A; Chaba A; Naorungroj T; Ow CPC; Lankadeva YR; May CN; Betrie AH; Lane DJR; Eastwood GM; Plummer MP; Bellomo R
    Crit Care; 2023 Oct; 27(1):371. PubMed ID: 37828547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial.
    Lyu QQ; Zheng RQ; Chen QH; Yu JQ; Shao J; Gu XH
    Crit Care; 2022 Sep; 26(1):295. PubMed ID: 36171582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous vitamin C administration to patients with septic shock: a pilot randomised controlled trial.
    Rosengrave P; Spencer E; Williman J; Mehrtens J; Morgan S; Doyle T; Van Der Heyden K; Morris A; Shaw G; Carr AC
    Crit Care; 2022 Jan; 26(1):26. PubMed ID: 35073968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial).
    Patel JJ; Willoughby R; Peterson J; Carver T; Zelten J; Markiewicz A; Spiegelhoff K; Hipp LA; Canales B; Szabo A; Heyland DK; Stoppe C; Zielonka J; Freed JK
    Chest; 2023 Feb; 163(2):303-312. PubMed ID: 36174744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
    Moskowitz A; Huang DT; Hou PC; Gong J; Doshi PB; Grossestreuer AV; Andersen LW; Ngo L; Sherwin RL; Berg KM; Chase M; Cocchi MN; McCannon JB; Hershey M; Hilewitz A; Korotun M; Becker LB; Otero RM; Uduman J; Sen A; Donnino MW;
    JAMA; 2020 Aug; 324(7):642-650. PubMed ID: 32809003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of IV vitamin C therapy in patients with sepsis or septic shock: a meta-analysis of randomized controlled trials.
    Liang B; Su J; Shao H; Chen H; Xie B
    Crit Care; 2023 Mar; 27(1):109. PubMed ID: 36915173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.
    François B; Lambden S; Fivez T; Gibot S; Derive M; Grouin JM; Salcedo-Magguilli M; Lemarié J; De Schryver N; Jalkanen V; Hicheur T; Garaud JJ; Cuvier V; Ferrer R; Bestle M; Pettilä V; Mira JP; Bouisse C; Mercier E; Vermassen J; Huberlant V; Vinatier I; Anguel N; Levy M; Laterre PF;
    Lancet Respir Med; 2023 Oct; 11(10):894-904. PubMed ID: 37269870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial.
    Sevransky JE; Rothman RE; Hager DN; Bernard GR; Brown SM; Buchman TG; Busse LW; Coopersmith CM; DeWilde C; Ely EW; Eyzaguirre LM; Fowler AA; Gaieski DF; Gong MN; Hall A; Hinson JS; Hooper MH; Kelen GD; Khan A; Levine MA; Lewis RJ; Lindsell CJ; Marlin JS; McGlothlin A; Moore BL; Nugent KL; Nwosu S; Polito CC; Rice TW; Ricketts EP; Rudolph CC; Sanfilippo F; Viele K; Martin GS; Wright DW;
    JAMA; 2021 Feb; 325(8):742-750. PubMed ID: 33620405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial.
    Petsakul S; Morakul S; Tangsujaritvijit V; Kunawut P; Singhatas P; Sanguanwit P
    BMC Anesthesiol; 2020 Nov; 20(1):280. PubMed ID: 33167911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial.
    Hwang SY; Park JE; Jo IJ; Kim S; Chung SP; Kong T; Shin J; Lee HJ; You KM; Jo YH; Kim D; Suh GJ; Kim T; Kim WY; Kim YJ; Ryoo SM; Choi SH; Shin TG;
    Trials; 2019 Jul; 20(1):420. PubMed ID: 31296251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary safety and efficacy of L-carnitine infusion for the treatment of vasopressor-dependent septic shock: a randomized control trial.
    Puskarich MA; Kline JA; Krabill V; Claremont H; Jones AE
    JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):736-43. PubMed ID: 23851424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis: The ORANGES Trial.
    Iglesias J; Vassallo AV; Patel VV; Sullivan JB; Cavanaugh J; Elbaga Y
    Chest; 2020 Jul; 158(1):164-173. PubMed ID: 32194058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
    Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
    JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EVALUATION OF HYDROCORTISONE, VITAMIN C, AND THIAMINE FOR THE TREATMENT OF SEPTIC SHOCK: A RANDOMIZED CONTROLLED TRIAL (THE HYVITS TRIAL).
    Mohamed A; Abdelaty M; Saad MO; Shible A; Mitwally H; Akkari AR; Elbuzidi A; Bintaher A; Hashim A; Abdelrahim M; Afzal M; El-Enany R; El-Hamid M; Bakdach D; Karic E; Shehatta A; Ibrahim AS; Lance M; Hssain AA; Hassan I
    Shock; 2023 May; 59(5):697-701. PubMed ID: 36870070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial-study protocol for a randomized controlled trial.
    Legrand M; Oufella HA; De Backer D; Duranteau J; Leone M; Levy B; Rossignol P; Vicaut E; Dépret F;
    Trials; 2020 Jul; 21(1):601. PubMed ID: 32611377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of vitamin C and thiamine for septic shock: a multi-centre, double-blinded randomized, controlled study.
    Hwang SY; Ryoo SM; Park JE; Jo YH; Jang DH; Suh GJ; Kim T; Kim YJ; Kim S; Cho H; Jo IJ; Chung SP; Choi SH; Shin TG; Kim WY;
    Intensive Care Med; 2020 Nov; 46(11):2015-2025. PubMed ID: 32780166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study on the melatonin treatment in patients with early septic shock: results of a single-center randomized controlled trial.
    Taher A; Shokoohmand F; Abdoli E; Mohammadi Y; Mehrpooya M
    Ir J Med Sci; 2022 Aug; 191(4):1913-1924. PubMed ID: 34468959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.